LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00021667
 53.04 27.76 810 5365 0.1510 0.5592
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
 53.04 27.76 7008 5365 1.3061 1.0716
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
 53.04 27.76 6467 5365 1.2052 1.0498
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
 53.04 27.76 6589 5365 1.2280 1.0548
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
 53.04 27.76 344 5365 0.0641 0.3930
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
 53.04 27.76 6047 5365 1.1270 1.0317
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
 54.74 27.76 475 5606 0.0847 0.4489
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
 54.74 27.76 5568 5606 0.9931 0.9982
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
 54.74 27.76 812 5606 0.1448 0.5540
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
 54.74 27.76 7450 5606 1.3288 1.0756
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
 54.74 27.76 6789 5606 1.2109 1.0506
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
 54.74 27.76 6909 5606 1.2323 1.0553
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
 54.74 27.76 344 5606 0.0614 0.3891
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
 54.74 27.76 6287 5606 1.1214 1.0301
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
 56.45 27.76 530 5745 0.0922 0.4672
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
 56.45 27.76 5841 5745 1.0166 1.0043
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
 56.45 27.76 890 5745 0.1549 0.5695
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
 56.45 27.76 7874 5745 1.3705 1.0836
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
 56.45 27.76 7067 5745 1.2300 1.0546
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
 56.45 27.76 7215 5745 1.2558 1.0601
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
 56.45 27.76 378 5745 0.0658 0.4042
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
 56.45 27.76 6626 5745 1.1533 1.0374
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
 58.15 27.76 509 5906 0.0862 0.4567
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
 58.15 27.76 6195 5906 1.0488 1.0124
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
 58.15 27.76 996 5906 0.1686 0.5888
MN20160318_Q01
J19